Man Group »

Lyell Immunopharma shares owned by Man Group

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Man Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $105k 54k 1.94

More positions owned by Man Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Qualcomm (QCOM)
Alphabet Cap Stk Cl C (GOOG)
Coca-Cola Company (KO)
Mastercard Incorporated Cl A (MA)
Equinix (EQIX)
Micron Technology (MU)
Merck & Co (MRK)

View all positions for Man Group

Top funds holding Lyell Immunopharma

BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
Alphabet
Geode Capital Management
Opaleye Management
Sc China Holding
FMR
Millennium Management
MIC Capital Management UK
Massachusetts Financial Services
Northern Trust
Charles Schwab Investment Management

View all funds holding Lyell Immunopharma